1. Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med (Lond). 2017;17(1):65-70.
2. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arth Rheum. 2006;54(8):2665-2673.
3. Queiro R, Sarasqueta C, Torre JC, Tinture T, López-Lagunas I. Prevalence and predictors of cervical involvement in psoriatic spondyloarthropathy. J Clin Rheumatol. 2002;8(1):23-29.
4. Scarpa R. Discovertebral erosions and destruction in psoriatic arthritis. J Rheumatol. 2000;27(4):975-978.
5. Giovannini I, Zabotti A, Cicciò C, et al Axial psoriatic disease: clinical and imaging assessment of an underdiagnosed condition. J Clin Med. 2021; 10(13):2845.
6. Salvarani C, Macchioni P, Cremonesi T, et al. The cervical spine in patients with psoriatic arthritis: A clinical, radiological and immunogenetic study. Ann Rheum Dis. 1992;51(1):73-77.
7. Sallés M, Clavaguera T, Mínguez S, Valencoso O, Lopez de Recalde M, Tuneu R. Atlantoaxial rotatory dislocation in a patient with psoriatic spondyloarthritis. Joint Bone Spine. 2019;86(4):519-521.
8. Singh JA, Guyatt G, Ogdie A, et al. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the treatment of psoriatic arthritis. Arth Rheumatol. 2019;71(1):25-32.
9. Gerriets V, Goyal A, Khaddour K. Tumor Necrosis Factor Inhibitors. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 3, 2023.
10. Ha AD, Jankovic J. Parkinsonism and dystonia associated with adalimumab. Mov Disord. 2011;26(8):1556-1558.
11. Peter I, Dubinsky M, Bressman S, et al. Anti-tumor necrosis factor therapy and incidence of parkinson disease among patients with inflammatory bowel disease. JAMA Neurol. 2018;75(8):939-946.
12. Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord. 1991;6(2):119-126.
13. Mercan FN, Akbostancı MC. Cervical dystonia and botulinum toxin treatment: when? Where? How Much? Turk Klin J Neurol-Special Topics. 2013;6(4):16-25.
14. Chu EC, Lo FS, Bhaumik A. Secondary atlantoaxial subluxation in isolated cervical dystonia-a case report. AME Case Rep. 2020;4:9.
15. Tonomura Y, Kataoka H, Sugie K, et al. Atlantoaxial rotatory subluxation associated with cervical dystonia. Spine (Phila Pa 1976). 2007;32(19): E561-E564.
16. Neeraja K, Prasad S, Surisetti BK, et al. Cervical myeloradiculopathy and atlantoaxial instability in cervical dystonia. World Neurosurg. 2021;146:e1287-e1292.
17. Kameda-Smith M, Biswas A, D’Arco F, Thompson D. Os odontoideum and craniovertebral junction instability secondary to dystonia: case series and review of the literature. Eur Spine J. 2024;33(3):1164-1170.
18. Masahiro K, Hidekazu T, Yutaka I, et al. Regression of retro-odontoid pseudotumor following Botulinum injection into cervical muscles. Surg Neurol Int. 2022;13:321.
19. Albanese A, Di Giovanni M, Lalli S. Dystonia: diagnosis and management. Eur J Neurol. 2019;26(1):5-17.
20. Mittal SO, Lenka A, Jankovic J. Cervical dystonia: an update on therapeutics. Expert Opin Orphan Drugs. 2019;7(4):1-11.